Medicine – Papilloedema Papilloedema is optic-disc swelling caused specifically by raised intracranial pressure (ICP). It is usually bilateral and represents transmission of increased intracranial pressure along the optic nerve sheath, producing impaired axoplasmic flow and swelling of the optic nerve head. An important terminology point is that not every swollen optic disc is papilloedema. Optic-disc swelling from hypertension, optic neuritis, retinal vein occlusion, or other local ocular disease is better described as optic-disc oedema unless raised intracranial pressure is responsible. 

1. Mechanism of Papilloedema The optic nerve is surrounded by meninges and a continuation of the intracranial subarachnoid space. When intracranial pressure rises, this increased pressure is transmitted along the optic nerve sheath toward the back of the eye. The resulting pressure disrupts normal axoplasmic transport within optic nerve fibres and produces swelling of the optic nerve head. The basic sequence is: Raised intracranial pressure → increased pressure around optic nerve → impaired axoplasmic flow → optic-disc swelling → papilloedema. 

2. Space-Occupying Intracranial Lesions An intracranial space-occupying lesion is an important cause of raised intracranial pressure and therefore papilloedema. Examples include: Brain tumour. Intracranial haematoma. Brain abscess. These lesions can increase ICP through their mass effect, surrounding cerebral oedema, obstruction of cerebrospinal fluid circulation, or a combination of these mechanisms. 

3. Brain Tumours Both primary and metastatic intracranial tumours can produce raised intracranial pressure. Associated symptoms may include progressive headache, vomiting, seizures, focal neurological deficits, personality or cognitive changes, depending on the tumour’s location. Papilloedema in this setting indicates raised ICP rather than direct tumour involvement of the eye. 

4. Intracranial Haematoma An intracranial haemorrhage or expanding haematoma can increase intracranial volume and produce raised ICP. Depending on the cause and speed of bleeding, the patient may present acutely with headache, altered consciousness, focal neurological signs, or signs of intracranial hypertension. 

5. Brain Abscess A brain abscess can behave as a space-occupying lesion. The abscess itself and surrounding cerebral oedema can increase intracranial pressure. Patients may have headache, fever, seizures, altered mental status, or focal neurological abnormalities, although the complete classic picture is not always present. 

6. Meningitis and Encephalitis Meningitis and encephalitis can increase intracranial pressure through inflammation, cerebral oedema, impaired cerebrospinal fluid absorption, or other complications. Papilloedema may therefore occur in severe cases. Its presence is clinically important because it suggests raised ICP and influences the safety and timing of investigations such as lumbar puncture. 

7. Subarachnoid Haemorrhage Subarachnoid haemorrhage (SAH) can produce a sudden increase in intracranial pressure. The classic presentation is a sudden severe “thunderclap” headache, often reaching maximal intensity rapidly. Vomiting, neck stiffness, photophobia, reduced consciousness, and neurological abnormalities may also occur. Papilloedema is not necessarily present immediately, but significant or sustained raised ICP can cause optic-disc swelling. 

8. Cerebral Oedema Cerebral oedema increases the volume of brain tissue within the fixed cranial cavity and can therefore raise intracranial pressure. It may occur following conditions such as severe brain injury, stroke, infection, hypoxic-ischaemic injury, or metabolic disturbances. Severe cerebral oedema can ultimately lead to brain herniation and is therefore potentially life-threatening. 

9. Idiopathic Intracranial Hypertension The older term benign intracranial hypertension is now generally replaced by idiopathic intracranial hypertension (IIH). The term “benign” is misleading because prolonged papilloedema can produce permanent visual-field loss and blindness. IIH is characterised by raised intracranial pressure without an intracranial mass lesion, hydrocephalus, or another clear structural explanation after appropriate investigation. 

10. Typical IIH Patient IIH occurs particularly commonly in women of reproductive age with obesity, although it can occur outside this group. Patients may present with: Headache. Transient visual obscurations. Pulsatile tinnitus. Diplopia, sometimes from a sixth cranial nerve palsy. Papilloedema. Visual-field monitoring is particularly important because persistent papilloedema can damage the optic nerves. 

11. Hypertensive Retinopathy The original notes list hypertensive retinopathy as a cause of papilloedema. This requires an important distinction. Severe hypertension, particularly a hypertensive emergency, can produce bilateral optic-disc swelling as part of severe hypertensive retinopathy. However, this is not necessarily papilloedema in the strict modern definition unless the disc swelling is caused by raised intracranial pressure. Other retinal findings may include flame haemorrhages, cotton-wool spots, hard exudates, and vascular abnormalities. 

12. Carbon Dioxide Retention Severe hypercapnia, or CO₂ retention, can increase cerebral blood flow because carbon dioxide causes cerebral vasodilatation. Marked hypercapnia may therefore increase intracranial pressure, particularly in susceptible patients. The relationship can be remembered as: ↑ PaCO₂ → cerebral vasodilatation → ↑ cerebral blood volume → ↑ ICP. Therefore, severe chronic or acute hypercapnia can occasionally contribute to papilloedema. 

13. Vitamin A Toxicity Excessive vitamin A exposure can produce a syndrome resembling idiopathic intracranial hypertension. Raised intracranial pressure can subsequently cause papilloedema. This association is especially relevant to excessive vitamin A intake and medications related to vitamin A. 

14. Vitamin A Analogues Retinoid medications, which are vitamin A derivatives, can cause intracranial hypertension in susceptible individuals. An important example is isotretinoin. Patients taking retinoids who develop persistent headache and visual symptoms require assessment for raised intracranial pressure. 

15. Tetracyclines Tetracycline-class antibiotics are another recognised medication association with intracranial hypertension. Examples include tetracycline, doxycycline, and minocycline. The clinical sequence is: Tetracycline exposure → intracranial hypertension → papilloedema. 

16. Retinoids and Tetracyclines The combination of tetracyclines and systemic retinoids is particularly important because both have associations with intracranial hypertension. Therefore, concurrent use is generally avoided. 

17. Lead Poisoning Severe lead poisoning has historically been associated with encephalopathy, cerebral oedema, raised intracranial pressure, and optic-disc swelling. This is now a relatively uncommon cause in many clinical settings but remains a recognised toxic association. Other features of significant lead toxicity can include abdominal symptoms, neurological abnormalities, anaemia, and cognitive or behavioural changes. 

18. Central Retinal Vein Occlusion The original notes list central retinal vein thrombosis, more commonly termed central retinal vein occlusion (CRVO). CRVO can cause optic-disc swelling, but it is not a true cause of papilloedema unless raised intracranial pressure is independently present. CRVO occurs because obstruction of retinal venous drainage produces retinal venous congestion. Fundoscopy classically demonstrates widespread retinal haemorrhages, dilated tortuous retinal veins, cotton-wool spots and optic-disc oedema—the classic “blood and thunder” appearance. Therefore: CRVO → optic-disc oedema, not usually true papilloedema. 

19. Cerebral Venous Sinus Thrombosis An important modern addition to the differential diagnosis is cerebral venous sinus thrombosis (CVST). CVST can impair cerebral venous drainage and cerebrospinal fluid absorption, producing raised intracranial pressure and true papilloedema. This is especially important because the presentation can sometimes resemble idiopathic intracranial hypertension. 

20. Clinical Features of Papilloedema Early papilloedema may produce relatively little reduction in central visual acuity. Patients may instead experience transient visual obscurations, in which vision temporarily dims or blacks out for several seconds. Other symptoms arise primarily from the underlying raised intracranial pressure. 

21. Symptoms of Raised Intracranial Pressure Important symptoms include: Headache. Nausea and vomiting. Transient visual obscurations. Pulsatile tinnitus. Diplopia, particularly from sixth nerve palsy. More severe intracranial disease may produce reduced consciousness or focal neurological abnormalities. 

22. Fundoscopic Appearance Typical features of established papilloedema include blurred optic-disc margins, elevation of the optic disc, hyperaemia, venous congestion, obscuration of vessels as they cross the disc margin, and sometimes peripapillary haemorrhages. The physiological optic cup may become progressively obscured as swelling increases. Papilloedema is generally bilateral, although the degree of swelling may be asymmetric. 

23. Vision in Early Papilloedema A useful examination point is that visual acuity can remain relatively normal during early papilloedema. This differs from many primary optic neuropathies, such as optic neuritis, where visual acuity and colour vision may deteriorate early. The blind spot may become enlarged because of swelling around the optic disc. 

24. Chronic Papilloedema If raised intracranial pressure persists, chronic papilloedema can progressively damage optic nerve fibres. Eventually the swollen optic discs may become pale as axons are lost. The sequence is: Raised ICP → papilloedema → chronic axonal injury → secondary optic atrophy → permanent visual loss. 

25. Papilloedema – Causes in Note Form Space-occupying lesions: brain tumour, intracranial haematoma and brain abscess can raise ICP. 

Meningitis/encephalitis: inflammation and cerebral oedema can increase intracranial pressure. 

Subarachnoid haemorrhage: acute intracranial bleeding can markedly increase ICP. 

Cerebral oedema: increased brain volume produces intracranial hypertension. 

Idiopathic intracranial hypertension: formerly called benign intracranial hypertension; an important cause of bilateral papilloedema. 

Cerebral venous sinus thrombosis: important secondary cause of intracranial hypertension and papilloedema. 

CO₂ retention: severe hypercapnia causes cerebral vasodilatation and can increase intracranial pressure. 

Vitamin A toxicity: can produce intracranial hypertension. 

Tetracyclines: recognised medication association with intracranial hypertension. 

Vitamin A analogues/retinoids: drugs such as isotretinoin can cause intracranial hypertension. 

Lead poisoning: severe toxicity can cause encephalopathy, cerebral oedema and raised ICP. 

Severe hypertensive retinopathy: can cause optic-disc oedema, but this should not automatically be called papilloedema. 

Central retinal vein occlusion: causes optic-disc oedema with widespread retinal venous congestion and haemorrhage, rather than true papilloedema in the strict sense. 

Key Clinical Pattern The most important definition to remember is: Papilloedema = optic-disc swelling specifically due to raised intracranial pressure. Therefore: Raised ICP → usually bilateral swollen optic discs → papilloedema. Important causes include: Intracranial mass + cerebral oedema + CNS infection + haemorrhage + IIH + cerebral venous sinus thrombosis + certain drugs/toxins. A particularly useful distinction is: Papilloedema → raised intracranial pressure. Optic neuritis → optic nerve inflammation, usually visual loss + pain on eye movement. CRVO → retinal venous obstruction + “blood and thunder” retina + optic-disc oedema. Chronic papilloedema → optic atrophy → irreversible visual loss.